Biomarker Discovery

ImmunoINSIGHTS™ Biomarker Discovery

Discover and validate novel autoantibody biomarkers signature to optimize patient stratification and predict immune-related adverse events.

Our high-throughput and multiplexed bead-based immunoassay discovery platform profiles relevant autoantibody biomarkers to address unmet needs and support the development of next generation precision medicine treatments.

Available pre-set panels and arrays:

  • Immuno-oncology
  • Autoimmune

All our panels include a set of protein antigens from our proprietary library and published biomarkers. Each panel can also be further customized to fit specific needs :

Categories included:

  • Tumor associated antigens, including cancer/testis antigens (e.g. MAGE-A)
  • Organ-specific antigens
  • Autoimmune disease antigens
  • Antigens involved in signaling pathways (e.g, MAPK, JAK/STAT, Wnt, NFκB, chemokines, VEGF, TGFβ, p53)
  • Antigens involved in cell cycle
  • Cytokine / Chemokine / Interleukin antigens
  • IVD gold standard antigens

ImmunoINSIGHTS™, our proprietary platform offers:

  • The world’s largest human antigen library including more than 8,000 human antigens available for interrogation
  • Best-in-class detection performance, reproducibility, dynamic range and robustness using high-throughput, bead-based multiplexed immunoassay technology, Luminex®.
  • Simultaneously detection of hundreds of targets in a single sample depending on panel design
  • Low sample volume – 50 μl per sample (serum & plasma and others) to identify IgG isoforms, in addition to IgM and IgA.
  • Learn more about our Technology

Explore all applications and disease areas: